News & analysis
Times are shown in GMT+1, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
Biosergen AB is a biotech company developing innovative antifungal drugs based on latest biopharmaceutical research and development from laboratory facilities in Trondheim, Norway and several other places worldwide. It is developing BSG005, a potentially disruptive antifungal drug, which has demonstrated significant safety and potency advantages over competing antifungals.
Latest BIOSGN News